[177Lu]Lu-DOTATATE Versus High-Dose Somatostatin Analogues in Advanced Gastroenteropancreatic Neuroendocrine Tumors: Pooled Evidence From 3 Phase 3 Randomized Trials.

Lutathera (lutetium Lu 177 dotatate) - Novartis

[177Lu]Lu-DOTATATE Versus High-Dose Somatostatin Analogues in Advanced Gastroenteropancreatic Neuroendocrine Tumors: Pooled Evidence From 3 Phase 3 Randomized Trials. (PubMed, Am J Ther) - Oct 17, 2026 - No abstract available
Journal • P3 data • Gastrointestinal Neuroendocrine Tumor • Neuroendocrine Tumor • Oncology • Pancreatic Cancer • Solid Tumor

http://www.ncbi.nlm.nih.gov/pubmed/42881497

Ahmad Sanan; Fnu Sawaira; Mohammad Omar Khan; Muhammad Arsalan; Muhammad Mughees; Muhammad Yasir; Taimoor Hassan; Zakir Ullah

Oct 17, 2026